GlaxoSmithKline
- Country
- π¬π§United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general med...
A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy
- Conditions
- First Posted Date
- 2003-02-05
- Last Posted Date
- 2010-10-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 345
- Registration Number
- NCT00053638
- Locations
- πΊπΈ
GSK Investigational Site, Green Bay, Wisconsin, United States
Effects of Antidepressants on Sexual Functioning
- Conditions
- First Posted Date
- 2003-01-08
- Last Posted Date
- 2010-10-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 420
- Registration Number
- NCT00051259
- Locations
- πΊπΈ
GSK Investigational Site, Madison, Wisconsin, United States
Effects Of Antidepressants On Sexual Functioning In Adults
- Conditions
- First Posted Date
- 2003-01-08
- Last Posted Date
- 2011-03-29
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 425
- Registration Number
- NCT00051272
- Locations
- πΊπΈ
GSK Investigational Site, Yakima, Washington, United States
Oral Drug Study In Women With Refractory Metastatic Breast Cancer After First-line or Second-line Herceptin.
- Conditions
- First Posted Date
- 2003-01-06
- Last Posted Date
- 2015-04-15
- Lead Sponsor
- GlaxoSmithKline
- Registration Number
- NCT00051103
- Locations
- πΊπΈ
GSK Investigational Site, Salem, Virginia, United States
Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer
- Conditions
- First Posted Date
- 2002-11-20
- Last Posted Date
- 2013-03-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 760
- Registration Number
- NCT00049998
- Locations
- π¬π§
GSK Investigational Site, London, United Kingdom
Major Depressive Disorder Study In Adults
- Conditions
- First Posted Date
- 2002-11-19
- Last Posted Date
- 2017-09-11
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 646
- Registration Number
- NCT00049972
- Locations
- πΊπΈ
GSK Clinical Trial Call Center, Kirkland, Washington, United States
Schizophrenia Study In Adults
- Conditions
- First Posted Date
- 2002-11-18
- Last Posted Date
- 2017-08-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 231
- Registration Number
- NCT00049946
- Locations
- πΊπΈ
GSK Clinical Trial Call Center, Terrell, Texas, United States
Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults
- Conditions
- First Posted Date
- 2002-10-31
- Last Posted Date
- 2013-02-12
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 162
- Registration Number
- NCT00048360
- Locations
- πΊπΈ
GSK Clinical Trials Call Center, Seattle, Washington, United States
A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder
- Conditions
- First Posted Date
- 2002-10-30
- Last Posted Date
- 2017-10-09
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 372
- Registration Number
- NCT00048204
Prevention of Seasonal Affective Disorder
- Conditions
- First Posted Date
- 2002-10-02
- Last Posted Date
- 2015-06-04
- Lead Sponsor
- GlaxoSmithKline
- Registration Number
- NCT00046449
- Locations
- πΊπΈ
Study SIte, Greenwood, Indiana, United States
π¨π¦Study Site, Hull, Quebec, Canada